Amplia Therapeutics Income Statement

Financials in millions AUD. Fiscal year is April - March.

Millions AUD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Other Revenue	5.01	3.78	4.45	1.19	1.98	1.53	Upgrade
Revenue	5.01	3.78	4.45	1.19	1.98	1.53	Upgrade
Revenue Growth (YoY)	46.79%	-15.02%	274.34%	-40.02%	29.33%	4380.44%	Upgrade
Cost of Revenue	0.3	0.21	0.44	0.31	0.15	0.31	Upgrade
Gross Profit	4.71	3.57	4.01	0.88	1.83	1.22	Upgrade
Selling, General & Admin	3.16	2.67	2.6	2.2	1.64	1.13	Upgrade
Research & Development	9.73	7.53	5.8	4.69	3.77	2.21	Upgrade
Operating Expenses	13.03	10.37	8.58	7.17	5.47	3.56	Upgrade
Operating Income	-8.32	-6.79	-4.57	-6.29	-3.64	-2.34	Upgrade
Interest Expense	-0.01	-0.06	-0.08	-0.05	-0	-	Upgrade
Interest & Investment Income	0.4	0.28	0.15	0.1	0	0	Upgrade
EBT Excluding Unusual Items	-7.93	-6.57	-4.5	-6.24	-3.64	-2.34	Upgrade
Other Unusual Items	-	-	-	-	-	0.06	Upgrade
Pretax Income	-7.93	-6.57	-4.5	-6.24	-3.64	-2.28	Upgrade
Net Income	-7.93	-6.57	-4.5	-6.24	-3.64	-2.28	Upgrade
Net Income to Common	-7.93	-6.57	-4.5	-6.24	-3.64	-2.28	Upgrade
Shares Outstanding (Basic)	394	307	194	194	146	95	Upgrade
Shares Outstanding (Diluted)	394	307	194	194	146	95	Upgrade
Shares Change (YoY)	75.83%	58.35%	0.02%	33.27%	53.71%	95.36%	Upgrade
EPS (Basic)	-0.02	-0.02	-0.02	-0.03	-0.03	-0.02	Upgrade
EPS (Diluted)	-0.02	-0.02	-0.02	-0.03	-0.03	-0.02	Upgrade
Free Cash Flow	-13.39	-6.89	-5.13	-5.31	-4.42	-2.92	Upgrade
Free Cash Flow Per Share	-0.03	-0.02	-0.03	-0.03	-0.03	-0.03	Upgrade
Gross Margin	94.06%	94.44%	90.07%	74.14%	92.20%	79.65%	Upgrade
Operating Margin	-166.25%	-179.51%	-102.64%	-528.45%	-183.72%	-152.60%	Upgrade
Profit Margin	-158.45%	-173.69%	-101.14%	-524.80%	-183.74%	-148.75%	Upgrade
Free Cash Flow Margin	-267.38%	-182.04%	-115.20%	-446.19%	-222.68%	-190.52%	Upgrade
EBITDA	-8.32	-6.78	-4.56	-6.28	-3.64	-2.34	Upgrade
EBITDA Margin	-166.19%	-179.24%	-102.40%	-	-183.56%	-152.56%	Upgrade
D&A For EBITDA	0	0.01	0.01	0.01	0	0	Upgrade
EBIT	-8.32	-6.79	-4.57	-6.29	-3.64	-2.34	Upgrade
EBIT Margin	-166.25%	-179.51%	-102.64%	-	-183.72%	-152.60%	Upgrade
Revenue as Reported	5.4	4.06	4.6	1.29	1.98	1.59	Upgrade

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.